Prospective Comparative Analysis of ACDF vs Fusion Interbody Cages With nanoLOCK Osseointegrative Technology
Cervical Radiculopathy, Cervical Myelopathy
About this trial
This is an interventional treatment trial for Cervical Radiculopathy focused on measuring spine, cervical, discectomy, bony fusion, dysphagia, radiographic fusion, radiographic adjacent segment disease
Eligibility Criteria
Inclusion Criteria: Subjects 18 years of age or older Subjects undergoing ACDF surgery for degenerative pathology (one, two or three levels) Subjects with no prior history of cervical spine surgery Subjects with complete/usable data Exclusion Criteria: Subjects under the age of 18 Subjects not undergoing ACDF surgery Subjects with prior cervical spine surgery Subjects with cervical neoplastic or infectious disease pathology Subjects with cervical trauma pathology ACDF performed at C2-3 Subjects with incomplete/unusable data
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Intervention Group
Control Group
Medtronic Titan Endoskeleton TCS zero-profile, stand-alone interbody cages with nanoLOCK osseointegrative technology will be implanted for participants in this group
Participants in this arm will receive an alternative interbody cage system that does not employ nanoLOCK ossteointegrative technology.